Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017

Volume: 497, Pages: 221 - 228
Published: Jan 1, 2021
Abstract
Recent research on genomic profiling of pancreatic ductal adenocarcinoma (PDAC) has identified many potentially actionable alterations. However, the feasibility of using genomic profiling to guide routine clinical decision making for PDAC patients remains unclear. We retrospectively reviewed PDAC patients between October 2013 and December 2017, who underwent treatment at the Johns Hopkins Hospital and had clinical tumor next-generation...
Paper Details
Title
Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017
Published Date
Jan 1, 2021
Volume
497
Pages
221 - 228
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.